Navigation Links
NutraCea Announces Conference Call to Report Second Quarter Financial Results
Date:12/20/2007

PHOENIX, Aug. 10 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a leader in stabilized rice bran nutrient research and technology, announced today it will report its second quarter financial results on Tuesday, August 14, 2007, after the financial markets close. There will be a conference call on Wednesday, August 15, 2007 at 11:30 AM EDT with the investment community, featuring Brad Edson, Chief Executive Officer and President of NutraCea, Todd Crow, Chief Financial Officer, and Leo Gingras, Chief Operating Officer.

Interested parties may participate in the call by dialing 877-407-8037; international callers dial 201-689-8037. In addition, the conference call will be available via a webcast that can be accessed at: http://www.vcall.com/IC/CEPage.asp?ID=119950 and will be archived for 30 days.

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufacturers as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual property to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the Company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com.

Company Contact: Investor Relations Contact:

Margie Adelman
'/>"/>

SOURCE NutraCea
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
2. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)... National Survey From American Humane Shows Publi... Hurricane Gustav Pet Evacuation Efforts Confirm ..., Sept. 5 /PRNewswire/ -- A 2007 survey by the Ame...Americans would refuse rescue,assistance if it mea...es,Hanna, Ike and Josephine moving towards the U.S...
(Date:9/5/2008)... FRANKLIN, Mass., Sept. 5 /PRNewswire/ -- Arthr...he developer of less-invasive joint,resurfacing sy...m the U.S.,FDA to begin its pivotal investigation ...he FDA stated that "there are no outstanding safet...initiation., Arthrosurface has been evaluating th...
(Date:9/5/2008)... MIDLOTHIAN, Va., Sept. 5 /PRNewswire/ -- On Sa...ll be featured on the Oxygen Network show Today,s,...ARI is highlighted as a,leading medical device com...s, with effective nebulizers and compressors that ... "Our vision is to improve the lives of those aff...
(Date:9/5/2008)...Study finds risk is greatest for those overweight ...HealthDay News) -- Almost half of all American adu... 85, and their odds increase if they are obese in ...k of having the painful condition increased as his...he University of North Carolina at Chapel Hill stu...
Breaking Medicine News(10 mins):Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2
...ge that victims of the terrible 'Elephant Man' cli... a 'reckless' rate.// The drug, a monoclonal anti...mia, multiple sclerosis and rheumatoid arthritis. ...t the victims had been injected 15 times faster th...
...lf of all children in the most rural counties of t...eas, according to a new study //by HHS Agency for ...published in the September-October 2006 issue of A... was led by AHRQ’s Frances Chevarley, Ph.D., analy...
...s can be treated with a low-priced antibiotic, acc...the limbs or scrotum. // A team of scientists at t...t doxycycline gave some relief to patients in the ...e. In addition, the antibiotic killed the causativ...
...earch has revealed that it is tougher to quit ment...be the reason for the excessive smoking-related di...lished in the Archives of Internal Medicine.Nearly...thol cigarettes like Kool or Newport in comparison...
Other Medicine News:Health News:Catastrophic Elephant Man Drug Trial Victims Injected Recklessly 2Health News:Local Health Care Limited for Rural Children 2Health News:Menthol cigarettes harder to quit than regular cigarettes 2
(Date:9/4/2008)...ctivity and favorable safety ...Newswire-FirstCall/ -- Idenix,Pharmaceuticals, Inc...gaged,in the discovery and development of drugs fo...s diseases, today announced that it has completed ...n-nucleoside reverse,transcriptase inhibitor (NNRT...
(Date:9/3/2008)...en Studied. Wrong,Conclusions Reached., NIXA, Mo.... Disease,Control and Prevention (CDC) study releas...accine and autism. The National Autism Association...growing public concern over a,vaccine-autism conne...gn,and methodology., For years, parents have clai...
(Date:9/3/2008)...se Awareness Month, CHARLOTTESVILLE, Va., Sept. 3...clinical-stage drug-development company commercial... needs, announced today that it has begun,to enrol...ead drug,candidate trans sodium crocetinate (TSC)....trials.gov Website, is investigating TSC as a trea...
(Date:9/3/2008)...ns with FDA, PRINCETON, N.J., Sept. 3 /PRNewswire...t it successfully completed two key clinical trial...ive low-dose, once-weekly,contraceptive patch, wh...code AG-200-15. The Phase 2b safety and efficacy s...ation suppression, cycle control and safety. The,p...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Chemistry turns killer gas into potential cure 805 1Chemistry turns killer gas into potential cure 805 2Testosterone turns male juncos into blustery hunks and bad dads 803 1Testosterone turns male juncos into blustery hunks and bad dads 803 2Testosterone turns male juncos into blustery hunks and bad dads 803 3Neuromed Concludes a Special Protocol Assessment 28SPA 29 with FDA for a Pivotal Phase 3 Study on NMED 1077 3669 1Neuromed Concludes a Special Protocol Assessment 28SPA 29 with FDA for a Pivotal Phase 3 Study on NMED 1077 3669 2Neuromed Concludes a Special Protocol Assessment 28SPA 29 with FDA for a Pivotal Phase 3 Study on NMED 1077 3669 3Holiday Entertaining with Style and Good Health 3667 1Holiday Entertaining with Style and Good Health 3667 2
Transcranial vascular DWL doppler.
Transcranial vascular DWL doppler.
Transcranil vascular DWL doppler.
...m Viasys Neurocare is a full-featured physiologic ...table size. It contains many of the features of ou...t an economical price. , ,The smaller size of ...ironment, the physician's office, a mobile service...
Medicine Products: